CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Nuuvera Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Nuuvera Inc
135 Devon Rd Unit 11
Phone: (416) 548-5998p:416 548-5998 BRAMPTON, ON  L6T 5A4  Canada Fax: (416) 548-5900f:416 548-5900
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Nuuvera Inc, formerly Mira IX Acquisition Corp is a Canada-based company engaged in the Cannabis industry which is working with partners in Germany, Israel, Malta and Italy, and is exploring opportunities in several other countries, to develop commercial production and distribution of medical grade cannabis in legalized markets. Through its subsidiaries, ARA Avanti Rx Analytics Inc. and Avalon Pharmaceutical Inc., The Company holds a Dealer License (GMP) under the Narcotic Control Regulations and Office of Controlled Substances.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/2017-Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Ronald D.Schmeichel
Chief Executive Officer, Director Lorne K.Abony 46
Chief Financial Officer JordanGreenberg
10 additional Officers and Directors records available in full report.

Business Names
Business Name
ASG Pharma
FL-Group SpA
MIA.P
NUU

General Information
Outstanding Shares: 4,270,799 (As of 12/31/2017)
Stock Exchange: CVE
Fax Number: (416) 548-5900


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023